Prevent severe pneumonia – use S. pneumoniae testing for early diagnosis

Pneumonia caused by Streptococcus pneumoniae is a leading cause of death among the elderly and people with chronic illness. The BIOSYNEX S. pneumoniae test makes it possible to identify infections early through a simple urine sample – and thereby initiate early treatment. This reduces complications, hospital admissions and mortality.

Rapid tests as part of infection preparedness

By implementing pneumococcal testing in elderly care, emergency departments and infectious disease wards, a faster clinical response can be achieved. The test requires no advanced setup and provides a clear result in 15 minutes. It is especially valuable where patients are unable to produce sputum.

Targeted health initiatives for risk groups

Particularly vulnerable groups, such as the elderly, immunocompromised individuals and patients with COPD, are at high risk of severe pneumonia. With regular screening and the use of rapid tests such as BIOSYNEX S. pneumoniae, the course of infection can be shortened and the prognosis improved. See also our other health tests.

Supports early treatment and antibiotic stewardship

The test result can be used to help target antibiotic treatment more quickly and reduce unnecessary use. In this way, the rapid test is also a tool in the fight against antibiotic resistance.

FAQ – early detection with S. pneumoniae testing

Who should be screened?

Older adults, people with weakened immune systems and patients with chronic lung diseases.

How is the test used?

A urine sample is dripped into the test cassette. The result can be read visually after 15 minutes.

Can the test be used without laboratory equipment?

Yes, the test is designed for point-of-care use without the need for specialised equipment.

What benefits does the test offer institutions?

Rapid identification of infections shortens the course of illness and allows better use of resources in the healthcare system.